Iqvia

Reimagine clinical development by intelligently connecting data, technology, iqvia, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster, iqvia. Reimagine a smarter, more productive future with an intelligent customer engagement platform that transforms the work of life science teams for real iqvia.

IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. IQVIA is the result of the merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider [9] The name of the modern company honors the legacy organizations. IMS Health was best known for its collection of healthcare information spanning sales, de-identified prescription data, medical claims, electronic medical records [10] and social media. Quintiles was the world's largest provider of biopharmaceutical development and commercial outsourcing services. The company offered clinical data management, clinical trial execution services, pharmaceuticals, drug development, financial partnering, and commercialization expertise to companies in the biotechnology, pharmaceutical and healthcare sectors. Throughout its history, the legacy IMS Health's business of collecting anonymized pharmaceutical sales data came under scrutiny from both the media and the legal system.

Iqvia

Innovative emerging biopharma and biotech companies are driving the drug development pipeline; competition for funding and resources is fierce. IQVIA Biotech delivers flexible clinical development solutions designed for the specific needs of biotech companies. When you partner with our clinical development team you gain expertise from more than two decades of running clinical trials exclusively for biotech companies, plus access to IQVIA's unparalleled data and technology. We understand the unique challenges and opportunities you face. From drug development strategy to trial design and execution, we draw on this experience to put together the right solution, and the right team, for you. The report provides clarity on the current landscape of EBP companies and their emerging product pipelines, as well as associated clinical trial activity and levels of trial success. In addition, the report focuses on the financial deals, technology and approaches to enable and accelerate these companies' efforts, profiling the drugs these companies have launched or originated, and an assessment of the success of launches in recent years including nuances beyond simply sales uptake. On the surface, your milestones may look the same as large pharma's. But we know that you face very different questions along your journey. The answers to those questions can impact not only your asset's probability of success, but that of your overall company. For emerging biopharma and biotech companies to excel in today's challenging environment, it's critical to leverage a deep understanding of the therapeutic area, regulatory pathways, patient profiles and market dynamics throughout the journey from clinical to commercial. Learn more about our comprehensive suite of end-to-end solutions, Asset Maximizer , delivered by experts dedicated to you, to help get your breakthrough to patients, faster. Flexible clinical solutions for biotech Your milestones. Your needs. Your team.

Modern Healthcare. Faster decision making and reduced risk so you can deliver life-changing therapies faster. Traded as, iqvia.

.

Orchestrate your clinical trials with transformative technologies to accelerate innovation, optimize efficiency, and deliver new treatments and vaccines to global markets faster. Molecule to market decisions. C-Suite decisions. Multi-stakeholder decisions. Getting treatments to market is increasingly complex, and market demands never stop growing. Clinical trials, launch planning, brand marketing, customer engagement, and patient support are more challenging to manage than ever before. By seamlessly connecting people, data, analytics and technology, IQVIA helps you accelerate the journey from data to insights to action so you can unleash new opportunities faster. The IQVIA Orchestrated Clinical Trials seamlessly integrates best of breed, modular, interoperable technologies proven to optimize efficiency and enhance trial outcomes. Digital Planning Suite Accurately predict study timeline, budget, and trial performance. Digital Site Suite Orchestrate better site-sponsor relationships.

Iqvia

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Lightstick exo

The Global Use of Medicines Copy Link. Connected Intelligence Advancing health and improving patient outcomes starts with intelligently connecting the right technology, insights, and stakeholders. IQVIA is the result of the merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider [9] The name of the modern company honors the legacy organizations. Designed for your patients Improve the patient experience, enhance data quality and accelerate clinical trials by combining best-in-class eCOA technology with industry-leading expertise. Learn more. For other uses, see Quintile disambiguation. July 9, - July 10, Contact Us. Cato Institute. An eCOA solution built for you. On the surface, your milestones may look the same as large pharma's.

IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services.

Discover a career with greater purpose. An update on progress and results. Retrieved 5 February Institute Reports. IMS Health Inc. Toggle limited content width. Email Us Get in touch today to discover the right solutions for you. Advancing Asset Value Across Milestones On the surface, your milestones may look the same as large pharma's. Forbes Magazine. Precision, speed, and scale meet the trust and reliability you need.